UCLH researchers to test new obesity treatment 

17/12/2018 00:00 

The UCL/UCLH Centre for Obesity is set to begin a clinical trial of a new weight loss treatment.

The Centre is one of 10 sites across the UK trialling the drug, semaglutide, which is understood to reduce hunger, food craving and body fat.

Researchers are looking for participants to take part in the trial, and would like to hear from patients interested in taking part and who:

  • Have a BMI of 30 or more, or 27 or more if you have another health problem like high blood pressure, high cholesterol or obstructive sleep apnoea (calculate your BMI here)
  • Do not have diabetes
  • Are not currently pregnant, breastfeeding or planning to become pregnant.

During the study, participants will need to:

  • Inject the study medicine once a week
  • Keep records of what they eat aand drink and their physical activity
  • Attend regular health checks and diet and exercise counselling sessions
  • Keep in contact with study staff

Contact: pajany.vythelingum@nhs.net or j.makaronidis@nhs.net

 Latest news

 GP Contact details

GP communications
2nd floor central
250 Euston Road
London NW1 2PG

General enquiries
Telephone: 020 3447 9083
Email: UCLH.gpqueries@nhs.net

GP web app:
Telephone: 020 3447 9000

GP enquiry lines and web app:
Call UCLH services direct from your smart phone or tablet: www.uclh.nhs.uk/mobile

Bookmark and Share
UCLH Instagram